Nearly 1 in 5 U.S. counties lacked opioid treatment programs or any office-based providers of buprenorphine, which reduces the risk of future overdoses, according to a federal review of whether
Adriel Bettelheim is a Senior Healthcare Editor for Axios, with a focus on national healthcare issues, particularly in the United States and the Tampa Bay area. His work has been featured in POLITICO and Yahoo News, and he covers a wide range of topics including FDA regulations, healthcare policy, pharmaceutical developments, and the impact of healthcare decisions on the American public.